Citation Information :
Gupta U, Shrivastava K, Katiyar G, Arif A, Gupta NK. Study of Efficacy and Safety of Ormeloxifene in the Management of Dysfunctional Menorrhagia. J South Asian Feder Menopause Soc 2014; 2 (1):1-4.
Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin. Gynecol Obstet Invest 2011;71(4):281-284.
Medical management of dysfunctional uterine bleeding. Baillieres Best Pract Res Clin Obstet Gynaecol 1999 Jun;13(2):189-202.
Medical management of menorrhagia. West J Med 2000 Apr;172(4):253-255.
Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev 2001;21(4):302-347.
Effect of ormeloxifene, a selective estrogen receptor modulator, on biomarkers of the endometrial receptivity and pinopode development and its relationship with fertility and infertility in Indian subjects. Fertil Steril 2009 Jun;91(6):2298-2307.
Centchroman a better alternative for hormonal oral contraceptive pills. Int J Pharm Bio Sci 2011 Jan-Mar;2(1):587-592.
‘The efficacy and safety of ormeloxifene in the management of menorrhagia: a pilot study’. J Obstet Gynaecol 2009;35(4):746-752.
The role of sevista in the management of dysfunctional uterine bleeding. J Clin Diagn Res 2013 Jan;7(1):132-134.
Ormeloxifene a selective estrogen receptor modulator, for treatment of dysfunctional menorrhagia. J Obstet Gynecol Ind 2004 Jan-Feb;54(1):56-59.
Efficacy of a selective estrogen receptor modulator: Ormeloxifene in management of dysfunctional uterine bleeding. J SAFOG 2010 Sep-Dec;2(6):207.